Phospho Antibodies
Tips and technical resources to kickstart your experiments and keep them moving forward, including concentration calculations, centrifuges, sample management, and more.
Phospho-specific antibodies are antibodies designed to recognize a protein only when it carries a phosphate group at a defined amino acid residue, typically serine, threonine, or tyrosine. Because phosphorylation is reversible and tightly regulated, these antibodies allow researchers to detect the active or inactive state of a protein at any given moment, rather than its mere presence.
Generation begins with designing a phosphopeptide antigen, which is a short peptide sequence containing the target amino acid in its phosphorylated form. This peptide is conjugated to a carrier protein and used to immunize a host animal. The resulting antibodies are then affinity-purified against the phosphopeptide and counter-selected against the non-phosphorylated version of the same sequence, ensuring specificity for the phosphorylated form only.
Yes, and this is actually a common and informative experimental approach. Running a phospho-specific antibody alongside a total protein antibody on the same or parallel blots lets you calculate the ratio of phosphorylated to total protein. This gives a clearer picture of actual signaling activity rather than just expression level, which can be misleading on its own.
The antibody's binding site is shaped to fit the phosphorylated epitope precisely. The phosphate group introduces a distinct structural and electrostatic signature that the antibody recognizes. If the phosphate is absent, the antibody either does not bind or binds with negligible affinity. This makes them highly selective tools for distinguishing active signaling states from baseline protein levels.
Phospho antibodies are used across a broad range of applications: detecting activated signaling pathways, studying cell cycle regulation, investigating apoptosis, characterizing kinase and phosphatase activity, and identifying disease-associated phosphorylation events. Technically, they are used in Western blotting, immunofluorescence, immunohistochemistry, flow cytometry, ELISA, and immunoprecipitation, among others.
Yes. They are classified primarily by the phosphorylated residue they target, which includes phosphoserine, phosphothreonine, and phosphotyrosine antibodies. Within these, antibodies can be site-specific (recognizing phosphorylation at a single defined residue on a specific protein) or pan-specific (recognizing a phosphorylated residue regardless of the surrounding sequence or protein context). Each type has distinct applications depending on the experimental question.
Phosphorylation is one of the most fundamental mechanisms cells use to switch proteins on or off. Without tools that can detect these transient modifications in real time, studying signal transduction, drug response, or disease mechanisms would be severely limited. Phospho antibodies have been central to breakthroughs in cancer biology, neuroscience, immunology, and metabolic research, making them indispensable in both basic and translational science.
Start with the specific phosphorylation site you need to detect and confirm the antibody has been validated for your application, including Western blot, IHC, flow cytometry, and so on. Check validation data: positive and negative controls, specificity testing against the non-phosphorylated form, and ideally knockout or phosphatase-treated samples. Species reactivity, host animal, and secondary antibody compatibility all matter too. Published literature citing the antibody in your cell or tissue type adds further confidence.
Phospho antibodies are available from a number of specialized life science suppliers. AAA Bio offers a curated catalog of phospho-specific antibodies with documented validation data across multiple applications. When purchasing from any source, prioritize suppliers that provide clear lot-specific testing, application-specific validation, and transparent information about the immunogen used.
The best phospho antibodies for Western blot are those validated specifically for that application under denaturing conditions, since SDS-PAGE disrupts native protein structure. Look for antibodies tested with positive controls, such as stimulated cell lysates, and negative controls, such as phosphatase-treated samples. Lot-to-lot consistency matters significantly here, as signal intensity can vary. Antibodies raised against phosphopeptides and affinity-purified tend to perform most reliably.
Robust validation involves several layers. Specificity is confirmed by testing against phosphorylated versus non-phosphorylated forms of the target peptide or protein. Functional validation uses stimulated cell lysates (where phosphorylation is induced) compared to unstimulated or phosphatase-treated controls. Application-specific validation under the actual experimental conditions the antibody will be used in is equally important. At AAA Bio, validation data is documented and made available so researchers can assess antibody performance before committing to an experiment.
Yes, cross-reactivity is a known limitation. A phospho antibody may bind to the same phosphorylated residue on structurally similar proteins, or occasionally to non-phosphorylated epitopes if purification was incomplete. This is why counter-selection against the non-phosphorylated peptide during production is critical, as is testing the antibody in relevant biological contexts. Always review the datasheet for known cross-reactivity and run appropriate controls.
Most phospho antibodies are raised in rabbits, as the rabbit immune system tends to generate high-affinity, high-specificity responses to small phosphopeptide antigens. Mouse-derived phospho antibodies also exist. Monoclonal phospho antibodies, particularly rabbit monoclonals, have become increasingly common because they offer the consistency of a single defined clone alongside the specificity advantages that come from rabbit immunization.
Several practical limitations exist. Phosphorylation is dynamic, so sample handling, lysis conditions, and the use of phosphatase inhibitors during preparation directly affect results. Epitope access can be poor in fixed or heavily cross-linked samples. Some antibodies lose sensitivity when a neighboring residue is also phosphorylated. Cross-reactivity with related proteins remains a concern, and validating antibodies across species or tissue types requires additional work. Understanding these constraints upfront leads to better experimental design and more interpretable data.
Contact us
Our expert team is here to help with your scientific queries and experiment needs via Chat, email, or phone. Let's make progress together.